Updated Jul 16, 2026
Chan Frank has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Chan Frank is an executive whose activity appears in SEC filings for Haemonetics Corporation. As of the most recent filing dated May 19, 2026, Frank held the position of Executive Vice President and Chief Operating Officer (COO) at Haemonetics. Publicly available biographical details beyond this SEC context are limited, and education, career history prior to Haemonetics, and other board or advisory roles are not verified in the provided material.
| Role | EVP, Chief Operating Officer |
|---|---|
| Notability | 45/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-19 | HAE | HAEMONETICS CORP | A — Grant or award | 27.5K | — | |
| 2026-05-19 | HAE | HAEMONETICS CORP | F — Tax withholding / forfeiture | 546 | $56.29 | $31K |
Chan Frank is an executive whose activity appears in SEC filings for Haemonetics Corporation. As of the most recent filing dated May 19, 2026, Frank held the position of Executive Vice President and Chief Operating Officer (COO) at Haemonetics. Publicly available biographical details beyond this SEC context are limited, and education, career history prior to Haemonetics, and ot…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Chan Frank profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.